Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis

Abstract

Peginterferon and ribavirin combination therapy was relatively effective and feasible for clinically diagnosed HCV patients, especially in those with genotype non-1 infection and low baseline viral load.